Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials
(University of Pennsylvania School of Medicine) Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases. One such strategy comes from a new abstract being presented Oct. 28 at the 15th World Conference on Lung Cancer from researchers at Perelman School of Medicine at the University of Pennsylvania studying mesothelioma.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Asbestosis | Cancer | Cancer & Oncology | Clinical Trials | Conferences | Health | International Medicine & Public Health | Lung Cancer | Mesothelioma | Study | University of Pennsylvania